A pharmacist collects Pfizer-BioNTech coronavirus vaccine syringes in San Rafael, Calif., on Sept. 22, 2021. (Jim Wilson/The New York Times)

Pfizer COVID vaccine’s benefits
outweigh risks in children: FDA

Pfizer reports data showing that its vaccine had a 90.7 percent efficacy rate in preventing symptomatic COVID-19 in a clinical trial of children aged 5 to 11